TVTX

Travere Therapeutics
TVTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.31B
EV
$1.39B
Shares Outstanding
88.80M
Beta
0.73

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$34.27
P/E 2025E
72.93x
P/Revenue 2025E
3.30x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Travere Therapeutics, Inc.

gainify
TVTX

Travere Therapeutics, Inc.

TVTX

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pa...

Sector

Healthcare

Industry

Biotechnology

CEO

Dube, Eric

Employees

385

IPO Date

2012-11-08

Headquarters

3611 Valley Centre Drive, Suite 300, San Diego, California, 92130, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.